GNRH1 and growth hormone-producing pituitary gland neoplasm: A high proportion of somatotroph tumors with a DG type was found in the LHRH responders than in the nonresponders [29 of 32 (91%) vs. 50 of 73 (68%); P < 0.05; Table 2].